相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic resistance of pancreatic cancer: Roadmap to its reversal
Sen Yu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions
Alain Couvineau et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
Aditi Jain et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
An Insight into GPCR and G-Proteins as Cancer Drivers
Preeti Kumari Chaudhary et al.
CELLS (2021)
Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target
Alain Couvineau et al.
MOLECULES (2021)
Early detection of pancreatic cancer using DNA-based molecular approaches
Aatur D. Singhi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
Heng Zhu et al.
MOLECULAR CANCER (2020)
Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines
Lukas M. Braun et al.
CELLS (2020)
The hypocretin (orexin) system: from a neural circuitry perspective
Shi-Bin Li et al.
NEUROPHARMACOLOGY (2020)
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
Aleksandr Ianevski et al.
NUCLEIC ACIDS RESEARCH (2020)
Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype
Abigail C. Cornwell et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer
Hui-Chen Ku et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner
Yi-Ru Pan et al.
BIOMOLECULES (2020)
Noncoding RNAs in drug-resistant pancreatic cancer: A review
Zhengjun Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Expression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2 in Pancreatic Ductal Adenocarcinoma
Eric M. Wang et al.
PANCREAS (2019)
Chemotherapy for pancreatic cancer
Christoph Springfeld et al.
PRESSE MEDICALE (2019)
The role and mechanisms of action of microRNAs in cancer drug resistance
Wengong Si et al.
CLINICAL EPIGENETICS (2019)
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
Alain Couvineau et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
The antioxidant transcription factor Nrf2 modulates the stress response and phenotype of malignant as well as premalignant pancreatic ductal epithelial cells by inducing expression of the ATF3 splicing variant ΔZip2
My-Lan Kha et al.
ONCOGENE (2019)
In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
Stéphanie Dayot et al.
Oncotarget (2018)
The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role
Alain Couvineau et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets
Subash Chandra Gupta et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs)
Li Wang et al.
PLOS ONE (2017)
Drug resistance in pancreatic cancer: Impact of altered energy metabolism
Cristoforo Grasso et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Gemcitabine resistance in pancreatic ductal adenocarcinoma
Yoav Binenbaum et al.
DRUG RESISTANCE UPDATES (2015)
Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer
Josep Tabernero et al.
ONCOLOGIST (2015)
Correlation Between Nuclear Factor E2-Related Factor 2 Expression and Gastric Cancer Progression
Hongyu Zheng et al.
MEDICAL SCIENCE MONITOR (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
High-throughput Image Analysis of Tumor Spheroids: A User-friendly Software Application to Measure the Size of Spheroids Automatically and Accurately
Wenjin Chen et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Aberrant Expression of OX1 Receptors for Orexins in Colon Cancers and Liver Metastases: an Openable Gate to Apoptosis
Thierry Voisin et al.
CANCER RESEARCH (2011)
A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism
Thierry Voisin et al.
FASEB JOURNAL (2008)
The role of HRK gene in human cancer
M. Nakamura et al.
ONCOGENE (2008)
HRK inactivation associated with promoter methylation and LOH in prostate cancer
Tomonori Higuchi et al.
PROSTATE (2008)
Effect of gemcitabine on the expression of a poptosis-related genes in human pancreatic cancer cells
Pei-Hong Jiang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Orexins acting at native OX1 receptor in colon cancer and neuroblastoma cells or at recombinant OX1 receptor suppress cell growth by inducing apoptosis
P Rouet-Benzineb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update
C Soldani et al.
APOPTOSIS (2002)
分享论文
